The short answer
The added bleeding risk from Panax ginseng with oxaprozin is uncertain. Review the exact product, dose and your bleeding history with your prescriber.
What this answer covers
Oral Panax ginseng with oral oxaprozin 600 mg tablets. Exact formulation, dose and duration matter; other NSAIDs and other supplement preparations are not interchangeable.
- Supplement or preparation
- Panax ginseng
- Medication ingredient
- oxaprozin
What the evidence shows
A small human study tested Panax ginseng alone and with aspirin. It found no clinically relevant overall added platelet or coagulation effect and no significant bleeding manifestations. Occasional individual platelet responses were observed. These short results do not establish a bleeding rate for this NSAID combination.
Consider this medicine’s own effects
Oxaprozin tablets carry warnings about serious GI bleeding, kidney injury and high potassium. The inspected product contains oxaprozin rather than an oxaprozin potassium salt. Its own warnings justify reviewing your history and other medicines, but they do not establish that every herb adds to bleeding risk.
Review the exact product
Show your pharmacist the Panax species, root preparation and dose. Other ginseng species and products with added herbs are different exposures. The available aspirin study does not justify assuming that every preparation increases bleeding or that all products are safe.
Know when to get help
oral oxaprozin 600 mg tablets can cause serious GI bleeding even without a supplement. Seek urgent care for vomiting blood or black, tarry stools, and report persistent stomach pain or unusual bleeding. Tell your prescriber about other pain medicines, aspirin and anticoagulants. A few hours of separation has not been shown to prevent an added bleeding effect.
Evidence and practical considerations
Side effects & toxicity
An increased bleeding or GI-injury rate specifically from Panax ginseng with oxaprozin has not been established.
- Exact scope
- Oral Panax ginseng with oral oxaprozin 600 mg tablets. Exact formulation, dose and duration matter; other NSAIDs and other supplement preparations are not interchangeable. with Exact oxaprozin IN 32613. These oral tablets contain oxaprozin, not an oxaprozin potassium product; the tablet strength is not supplemental potassium.
- Medication form and route
- Oral
What remains uncertain
- Available supplement-only and other-drug studies do not establish exact-pair clinical harm or exclude rare events. No validated preventive spacing interval.
Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Prescription oral oral oxaprozin 600 mg tablets users; short human pharmacology studies where described.
Serious GI bleeding, renal toxicity and hyperkalemia warnings apply; medicines affecting hemostasis warrant review. No exact botanical risk rate.
How this applies: Exact current product label. Exact oxaprozin IN 32613. These oral tablets contain oxaprozin, not an oxaprozin potassium product; the tablet strength is not supplemental potassium.
Exact oral product label; no measured botanical co-use incidence. Ingredient, route, preparation and comparator differences must be retained.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Approximately 25 healthy volunteers assigned per herb.
No clinically relevant overall platelet/coagulation change or added aspirin inhibition. No significant bleeding manifestations reported.
How this applies: Indirect for oral oxaprozin 600 mg tablets co-use; exact preparation and endpoint retained.
Abstract-only; small short study, preparation detail incomplete. Occasional individual platelet responses do not establish clinical bleeding; rare harm or different products not excluded.
Source 3: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
oxaprozin is IN.
How this applies: Exact identity.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: cb7fc4d9cbd6b612
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.